Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Mrs Ekaterini Lambrinou,
Heart failure is a complex syndrome accounting for numerous complications and adverse events which should be treated in a timely manner. Thus, close monitoring of the patients is deemed essential.This interesting session focused on new concepts of remote monitoring in heart failure and was co-chaired by professor Massimo F Piepoli and myself.
The session opened with Dr Jillian Riley ( London,GB) who presented remote monitoring and how it is included in heart failure management programmes and reviewed the data available from clinical trials. She explained that the team of health care professionals should be educated in telemonitoring issues, but also in transferring this kind of knowledge to patients.
Patients have a key role to play in accepting and participating in remote telemonitoring. At the end of her lecture, Dr Riley challenged the audience referring to the roles between professionals and roles between professionals and patients.
Dr WT Abraham (Columbus, US) followed by discussing and explaining the results of the latest meta-analysis on telemonitoring. He also presented the latest clinical trials and new technologies that have been developed, pointing out that remote telemonitoring combined with other device diagnostics can be used as a risk stratification tool. At the end of his talk, Dr Abraham placed the patient in the centre and showed how he can self-manage his treatment using telemonitoring, always in cooperation with his doctor.
Dr F Koehler ( Berlin,DE) began his lecture by discussing the transfer of remote telemonitoring from clinical trials to clinical practice, highlighting the differences in national regulations between different countries. He also discussed the roles of several health care professionals involved in telemonitoring management programmes.
The session was brought into a close by Professor MR Cowie (London, GB) who started his lecture with the EU vision ‘eHealth action plan 2012-2020’.
He also highlighted the patient’s complex journey and the importance of how data should be presented, how often and to whom. At the end of his speech, he challenged the audience to think about how available sources can be used in a more effective way in the best interest of patients and health care systems.
Session Title: Remote monitoring in heart failure: new concepts
© 2017 European Society of Cardiology. All rights reserved